Literature DB >> 28545782

Autoimmune Encephalopathy for Psychiatrists: When to Suspect Autoimmunity and What to Do Next.

Mark Oldham1.   

Abstract

OBJECTIVE: To provide a critical review of autoimmune encephalopathy-broadly defined as neuropsychiatric features directly related to an autoimmune process-relevant for psychiatric practice.
METHODS: We consulted rheumatology textbooks to define the scope of autoimmune conditions and identified recent reviews of rheumatic conditions, autoimmune vasculitis, and autoimmune encephalitis. We integrated these with primary reports to provide a clinically relevant overview of autoimmune encephalopathy. We focus on clinical features that should raise suspicion for autoimmunity.
RESULTS: Despite outlying conditions, 2 categories of autoimmune encephalopathy are described: (1) neuropsychiatric symptoms associated with rheumatic conditions and (2) antibody-associated autoimmune encephalitis. Rheumatic conditions principally include connective tissue disease and other vasculitides. These may present variously such as with unexplained delirium, cognitive decline, or depression. Autoimmune encephalitis may be diffuse or localized as in limbic, brainstem, or basal ganglia encephalitis. Unexplained delirium, psychosis, catatonia, strokes, and seizures are among common presenting symptoms.
CONCLUSIONS: Prompt identification and management of autoimmunity are critical for optimal outcomes. The fact that undiagnosed and, therefore, untreated autoimmunity leads to debilitation demands vigilance for these conditions. Close attention to the unusual nature and course of neuropsychiatric symptoms, associated neurological features, and review of systems as reviewed here should guide the skillful clinician.
Copyright © 2017 The Academy of Psychosomatic Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  anti-NMDA receptor; autoimmune encephalopathy; encephalitis; limbic encephalitis; paraneoplastic encephalitis.; rheumatic disease

Mesh:

Year:  2017        PMID: 28545782     DOI: 10.1016/j.psym.2017.02.014

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  5 in total

1.  [Autoantibody-associated schizophreniform psychoses: pathophysiology, diagnostics, and treatment].

Authors:  Ludger Tebartz van Elst; Karl Bechter; Harald Prüss; Alkomiet Hasan; Jo Hann Steiner; Frank Leypoldt; Dominique Endres
Journal:  Nervenarzt       Date:  2019-07       Impact factor: 1.214

Review 2.  Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions.

Authors:  Michelle A Erickson; William A Banks
Journal:  Pharmacol Rev       Date:  2018-04       Impact factor: 25.468

3.  Probable Autoimmune Depression in a Patient With Multiple Sclerosis and Antineuronal Antibodies.

Authors:  Dominique Endres; Sebastian Rauer; Nils Venhoff; Patrick Süß; Rick Dersch; Kimon Runge; Bernd L Fiebich; Kathrin Nickel; Miriam Matysik; Simon Maier; Katharina Domschke; Karl Egger; Harald Prüss; Ludger Tebartz van Elst
Journal:  Front Psychiatry       Date:  2020-08-13       Impact factor: 4.157

4.  Cost-Effectiveness of Routine Screening for Autoimmune Encephalitis in Patients With First-Episode Psychosis in the United States.

Authors:  Eric L Ross; Jessica E Becker; Jenny J Linnoila; Djøra I Soeteman
Journal:  J Clin Psychiatry       Date:  2020-11-17       Impact factor: 4.384

Review 5.  Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations.

Authors:  Dominique Endres; Frank Leypoldt; Karl Bechter; Alkomiet Hasan; Johann Steiner; Katharina Domschke; Klaus-Peter Wandinger; Peter Falkai; Volker Arolt; Oliver Stich; Sebastian Rauer; Harald Prüss; Ludger Tebartz van Elst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-03-12       Impact factor: 5.270

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.